CTRI/2024/07/070255尚未招募Unknown
Seroprevalence and outcome of Hepatitis B and C infections in antenatal women - NI
Government Medical College ang Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Pregnant women visiting the outpatient department and labour room will be screened for HBV and HCV infection and seropositive women will be studied for maternal and fetal outcomes.
排除标准
- •None as hepatitis B and C screening is recommended for all pregnant women.
研究者
相似试验
进行中（未招募）
不适用
The cost-effectiveness study of population-based screening of hepatitis C virus (HCV) infection: Evidence for effective control of HCV in KoreaDiseases of the digestive systemKCT0002077Seoul National University Bundang Hospital15,000
进行中（未招募）
不适用
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyEUCTR2006-000421-62-GRBristol-Myers Squibb International Corporation462
进行中（未招募）
不适用
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir Plus Tenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 6.1Level: PTClassification code 10019731EUCTR2006-000421-62-ITBristol-Myers Squibb International Corporation462
进行中（未招募）
1 期
A Comparative Study of Chronic Hepatitis B Subjects Treated with Entecavir PlusTenofovir Combination Therapy vs Entecavir Monotherapy in Adults who are Treatment-Naïve to Nucleosides and Nucleotides: The BE-LOW Study.Revised Protocol 01, incorporating protocol amendment 02 (Version 2.0, Date 22-Jan-07). - The BE-LOW StudyCHRONIC HEPATITIS B VIRUS,TREATMENT-NAIVMedDRA version: 8.1Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)EUCTR2006-000421-62-FRBristol-Myers Squibb International Corporation462
已完成
2 期
Comparing the Efficacy and Safety of Hepatitis B vaccine of Pasteur Institute of Iran and Cuban Heber biotec Company’s in Iranian healthy volunteersCondition 1: Acute Hepatitis B. Condition 2: Chronic (viral) hepatitis B.Acute hepatitis BChronic (viral) hepatitis BIRCT201109113307N5Pasteur Institute of Iran (IPI)440